In Vitro Perspective on Hypofractionated Radiotherapy in Breast Cancer
Preprint
- 27 January 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The rising incidence of breast cancer, particularly evident during the COVID-19 pandemic, 19 highlights the need to investigate effective treatment options, especially in resource-limited countries such as those 20 in Sub-Saharan Africa. This study aims to evaluate the in vitro effects of hypofractionated versus conventionally 21 fractionated radiotherapy on various breast cell lines. The responses of breast cell lines including MCF-7 (hormone 22 receptor-positive), MDA-MB-231 (triple-negative), and MCF-10A (non-cancerous) to cobalt-60 γ-rays were 23 assessed. Key radiobiological endpoints included clonogenic survival, adaptive responses, migration, invasion, 24 and cytotoxicity measured through lactate dehydrogenase assays. Findings reveal that α/β ratios for breast cancer 25 cells varied from 2.5 to 5.4 Gy. Notably, hypofractionation reduced survival in hormone receptor-positive cells, 26 while triple-negative cells exhibited increased survival. Additionally, adaptive radiation responses increased 27 viability across all lines, and the non-cancerous (MCF-10A) cell line showed reduced migration post-treatment. 28 These results highlight the importance of personalised radiation therapy, optimising treatment strategies based on 29 specific breast cancer subtypes to potentially improve patient outcomes.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Hypofractionation: The standard for external beam breast irradiationThe Breast, 2023
- Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central MassachusettsCancer Causes & Control, 2022
- Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Patient-reported treatment delays in breast cancer care during the COVID-19 pandemicBreast Cancer Research and Treatment, 2020
- In vitro assays and techniques utilized in anticancer drug discoveryJournal of Applied Toxicology, 2018
- Metabolic targets of watercress and PEITC in MCF-7 and MCF-10A cells explain differential sensitisation responses to ionising radiationEuropean Journal of Nutrition, 2018
- Molecular Heterogeneity of Triple-Negative Breast CancerCurrent Breast Cancer Reports, 2014
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Thirteen new p53 gene mutants identified among 41 human breast cancer cell linesBreast Cancer Research and Treatment, 2006
- A review of ratios for experimental tumors: Implications for clinical studies of altered fractionationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985